In August, Rybrevant was approved in combination with lazertinib for the first-line treatment of locally advanced or metastatic NSCLC with EGFR exon 19 deletions or L858R substitution mutations
For example, 40 mg in 4 mL is 10 mg/mL
L-carnitine is a naturally occurring amino acid that is key for transporting fatty acids into the mitochondria of cells, where they can be used as a source of energy
Phase 2 trial data covering 48 weeks shows a safety profile comparable to other approved incretin-based therapies
Trials and real-world data have established oral semaglutide as an extremely effective option for glycated hemoglobin (HbA1c) reduction across various durations of disease, backgrounds of therapy, and comorbidities [5, 6]
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved its use, and it is increasingly prescribed for glycaemic control